PRMB
Primo Brands Corporation
$20.00
+1.06% 2026-10-20
Consumer Defensive
PRMBSPY
1W
+5.8%
1M
-2.5%
3M
-15.1%
6M
+1.3%
YTD
+24.3%
1Y
-7.8%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsPrimo Brands Receives International Bottled Water Association's 2026 Environmental Stewardship Award
PR Newswire · 12h ago
Primo Brands opens first new factory post merger
Food Dive · Oct 19
Deutsche Bank Adjusts Primo Brands Price Target to $21 From $25, Maintains Hold Rating
MT Newswires · Oct 19
Is Primo Brands (PRMB) Undervalued As Its New Water Facility Comes Online?
Simply Wall St. · Oct 15
Primo Brands (PRMB) Stock Looks About Right Following New Factory Opening
Simply Wall St. · Oct 15
Key stats
Market cap$7.2B
P/E (trailing)66.7
P/E (forward)13.5
52-week range14.36 – 26.21
Revenue growth (YoY, latest qtr)+3.8%
Dividend yield2.43%
Analyst consensusBuy (11)
Mean price target$29.36 (+47%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score -2 (DCF counts double).
▼Piotroski F-score3/9
▼Altman Z1.1 (distress)
▼Net debt / EBITDA4.3x
▲Analyst target+47% (11 analysts)
Discounted cash flow
Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.69 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $1.48 vs trailing $0.30 (+393% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
29.2%
Operating margin
7.2%
FCF margin
–
Net margin
1.5%
Return on equity
3.4%
Return on invested capital
4.0%
Net debt / EBITDA
4.3×
Current ratio
1.1×
Interest cover
1.5×
Cash conversion (OCF/NI)
–
Piotroski F-score 3/9 · last two fiscal years
✓ Positive net income✗ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✗ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✗ Gross margin improved✓ Asset turnover improved
Altman Z-score 1.1 (distress zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$29
+47%
Analysts
11
Buy
Range
$21–$35
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $6.7B | $60.1M | – |
| 2024 | $5.2B | $-16.4M | – |
| 2023 | $4.7B | $92.8M | – |
| 2022 | $4.4B | $-126.7M | – |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +14.5%.
Earnings
Next report: 2026-11-05 · before open · EPS est 0.43
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | 0.33 | 0.37 | +10.6% |
| 2026-05-07 | 0.24 | 0.23 | -5.1% |
| 2026-02-26 | 0.20 | 0.26 | +27.9% |
| 2025-11-06 | 0.36 | 0.41 | +13.4% |
| 2025-08-07 | 0.41 | 0.36 | -13.1% |
| 2025-05-08 | 0.23 | 0.29 | +24.0% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.8B | +3.8% |
| 2026-03-31 | $1.6B | – |
| 2025-12-31 | $1.6B | – |
| 2025-09-30 | $1.8B | – |
| 2025-06-30 | $1.7B | – |
Analyst actions
Barclays
PT $26
2026-10-16 · main
Overweight → OverweightPT $26
RBC Capital
PT $31
2026-08-07 · main
Outperform → OutperformPT $31
Barclays
PT $29
2026-08-07 · main
Overweight → OverweightPT $29
Barclays
PT $27
2026-07-21 · main
Overweight → OverweightPT $27
JP Morgan
PT $29
2026-07-16 · main
Overweight → OverweightPT $29
Barclays
PT $25
2026-05-11 · main
Overweight → OverweightPT $25
Recent dividends
2026-08-24: $0.120 · 2026-06-04: $0.120 · 2026-03-06: $0.120 · 2025-11-25: $0.100 · 2025-08-21: $0.100 · 2025-06-06: $0.100 · 2025-03-07: $0.100 · 2024-11-22: $0.090
Insider trades
Foss Eric J
$2.0M
Director, Exec. Chair and CEO · 2026-08-10
BUY$2.0M
Foss Eric J
$2.4K
Director, Exec. Chair and CEO · 2026-08-10
BUY$2.4K
Orcp Iii De Topco Gp, Llc
$497.4M
10% owner · 2026-08-07
SELL$497.4M
Lee Tony W
$497.4M
Director, 10% owner · 2026-08-07
SELL$497.4M
None
–
None · None
SELL–
Stats refreshed 2026-10-20 18:03:30 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.